Mesothelin is a biomarker of tumor aggressiveness and therapy response in malignant pleural mesothelioma (MPM) Meeting Abstract


Authors: Servais, E. L.; Colovos, C.; Suzuki, K.; Velez, M.; Rodriguez, L.; Sima, C.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
Abstract Title: Mesothelin is a biomarker of tumor aggressiveness and therapy response in malignant pleural mesothelioma (MPM)
Meeting Title: 65th Annual Owen H Wangensteen Surgical Forum 2010 Clinical Congress
Journal Title: Journal of the American College of Surgeons
Volume: 211
Issue: 3 Suppl.
Meeting Dates: 2010 Oct 3-7
Meeting Location: Washington, DC
ISSN: 1072-7515
Publisher: Elsevier Science, Inc.  
Date Published: 2010-09-01
Start Page: S36
Language: English
ACCESSION: ISI:000281708600063
PROVIDER: wos
Notes: --- - Meeting Abstract - Suppl. S - "Source: Wos"
MSK Authors
  1. Camelia S Sima
    204 Sima
  2. Valerie W Rusch
    655 Rusch
  3. Elliot Louis Servais
    17 Servais
  4. Kei Suzuki
    28 Suzuki
  5. Michel W J Sadelain
    456 Sadelain
  6. Christos Colovos
    16 Colovos
  7. Marissa Christina Velez
    1 Velez